electroCore, Inc., (NASDAQ: ECOR) :: Is Now An Attractive Investment
By NNF Team -August 3, 2020
https://nasdaqnewsfeed.com/2020/08/03/electrocore-inc-nasdaq-ecor-is-now-an-attractive-investment-2/
[-chart]nasdaqnewsfeed.com/wp-content/uploads/2020/02/NasdaqNewsFeed-8.jpg[/chart]
EPS growth is an important number as it gives a suggestion of the future prospects of a company. It is usually expressed as a percentage and is then referred to as the EPS growth rate. Growth in EPS is an important measure of administration performance because it shows how much money the company is making for it’s investors or shareholders, not only because of changes in profit, but also after all the effects of issuance of new shares (this is especially important when the growth comes as a result of acquisition).
electroCore, Inc., belongs to Healthcare sector and Medical Instruments & Supplies industry. The company’s Market capitalization is $83.38M with the total Outstanding Shares of 6. On 31-07-2020 (Friday), ECOR stock construct a change of 44.81 in a total of its share price and finished its trading at 2.23.
Profitability Ratios (ROE, ROA, ROI):
Looking into the profitability ratios of ECOR stock, an investor will find its ROE, ROA, ROI standing at 0%, 0% and -189%, respectively. Return on assets (ROA) is a financial ratio that shows the percentage of profit a company earns about its overall resources. A performance measure used to estimate the efficiency of an investment or to compare the ability of some different investments. ROI measures the amount of return on an investment relative to the investment’s cost.
Earnings per Share Details of electroCore, Inc.:
The EPS of ECOR is strolling at -1.33, measuring its EPS growth this year at 19.4%. As a result, the company has an EPS growth of 31.1% for the approaching year.
Given the significance of identifying companies that will make sure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.
We can’t have sufficient maintenance the once will always replicate the difficult, but logically stocks that have grown earnings per allowance strongly in the subsequent to are a fine bet to keep on to take effect as a result.
Analyst’s mean target price for the company is $0 while analysts mean suggestion is 2.5.
A beta factor is used to measure the volatility of the stock. The stock remained 14.23% volatile for the week and 16.04% for the month.
Historical Performance In The News:
Taking a look at the performance of electroCore, Inc. stock, an investor will come to know that the weekly performance for this stock is valued at 38.51%, resulting in a performance for the month at 180.5%.
Therefore, the stated figure displays a quarterly performance of 137.16%, bringing six-month performance to 76.98% and year to date performance of 40.25%.
P/S, P/E, P/C and P/B/ SMA50, SMA 200:
The price-to-sales is a valuation ratio that relates a company’s stock price to its revenues. The price-to-sales ratio is a symbol of the value placed on each dollar of a company’s sales or taxes. As of now, ECOR has a P/S, P/E and P/B values of 30.88, 0 and 3.91 respectively. P/E and P/B ratios both are used on a regular basis by the investor to measure the value of the company and to get the right amount of the share.
Its EPS growth is an important number as it gives a suggestion of the future prospects of a company. It is usually expressed as a percentage and is then referred to as the EPS growth rate. Growth in EPS is an important measure of administration performance because it shows how much money the company is making for it’s investors or shareholders, not only because of changes in profit, but also after all the effects of issuance of new shares (this is especially important when the growth comes as a result of acquisition).
electroCore, Inc., belongs to Healthcare sector and Medical Instruments & Supplies industry. The company’s Market capitalization is $83.38M with the total Outstanding Shares of 6. On 31-07-2020 (Friday), ECOR stock construct a change of 44.81 in a total of its share price and finished its trading at 2.23.
Profitability Ratios (ROE, ROA, ROI):
Looking into the profitability ratios of ECOR stock, an investor will find its ROE, ROA, ROI standing at 0%, 0% and -189%, respectively. Return on assets (ROA) is a financial ratio that shows the percentage of profit a company earns about its overall resources. A performance measure used to estimate the efficiency of an investment or to compare the ability of some different investments. ROI measures the amount of return on an investment relative to the investment’s cost.
Earnings per Share Details of electroCore, Inc.:
The EPS of ECOR is strolling at -1.33, measuring its EPS growth this year at 19.4%. As a result, the company has an EPS growth of 31.1% for the approaching year.
Given the significance of identifying companies that will make sure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.
We can’t have sufficient maintenance the once will always replicate the difficult, but logically stocks that have grown earnings per allowance strongly in the subsequent to are a fine bet to keep on to take effect as a result.
Analyst’s mean target price for the company is $0 while analysts mean suggestion is 2.5.
A beta factor is used to measure the volatility of the stock. The stock remained 14.23% volatile for the week and 16.04% for the month.
Historical Performance In The News:
Taking a look at the performance of electroCore, Inc. stock, an investor will come to know that the weekly performance for this stock is valued at 38.51%, resulting in a performance for the month at 180.5%.
Therefore, the stated figure displays a quarterly performance of 137.16%, bringing six-month performance to 76.98% and year to date performance of 40.25%.
P/S, P/E, P/C and P/B/ SMA50, SMA 200:
The price-to-sales is a valuation ratio that relates a company’s stock price to its revenues. The price-to-sales ratio is a symbol of the value placed on each dollar of a company’s sales or taxes. As of now, ECOR has a P/S, P/E and P/B values of 30.88, 0 and 3.91 respectively. P/E and P/B ratios both are used on a regular basis by the investor to measure the value of the company and to get the right amount of the share.
Its P/Cash valued at 5.34. The price-to-cash-flow ratio is a stock valuation indicator that measures the value of a stock’s price to its cash flow per share
What do you mean by simple moving average (SMA)?
A simple moving average (SMA) is an arithmetic moving average calculated by adding the closing price of the security for some time periods and then dividing this total by the number of time periods. Its distance from 20-days simple moving average is 60.11%, and its distance from 50 days simple moving average is 98.56% while it has a distance of 88.92% from the 200 days simple moving average. The company’s distance from 52-week high price is 6% and while the current price is 6% from 52-week low price.
TAGSECORelectroCoreInc.NASDAQ: ECOR The price-to-cash-flow ratio is a stock valuation indicator that measures the value of a stock’s price to its cash flow per share
What do you mean by simple moving average (SMA)?
A simple moving average (SMA) is an arithmetic moving average calculated by adding the closing price of the security for some time periods and then dividing this total by the number of time periods. Its distance from 20-days simple moving average is 60.11%, and its distance from 50 days simple moving average is 98.56% while it has a distance of 88.92% from the 200 days simple moving average. The company’s distance from 52-week high price is 6% and while the current price is 6% from 52-week low price.
TAGSECORelectroCoreInc.NASDAQ: ECOR
Recent ECOR News
- electroCore Announces the Launch of Truvaga Plus® for General Wellness • GlobeNewswire Inc. • 04/08/2024 12:30:00 PM
- electroCore Expands Intellectual Property Portfolio • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- electroCore Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/13/2024 08:05:00 PM
- electroCore to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/05/2024 09:05:00 PM
- electroCore Expands Intellectual Property Portfolio • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:00:51 PM
- electroCore Expands Intellectual Property Portfolio • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:16:30 PM
- electroCore Expands Intellectual Property Portfolio • GlobeNewswire Inc. • 12/26/2023 01:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 09:15:23 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 12/18/2023 09:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 10:15:26 PM
- electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/07/2023 12:53:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 11:11:39 AM
- Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023 • GlobeNewswire Inc. • 11/15/2023 01:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:16:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:11:31 PM
- electroCore Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/08/2023 09:01:00 PM
- electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting • GlobeNewswire Inc. • 10/24/2023 12:00:00 PM
- electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue • GlobeNewswire Inc. • 10/17/2023 12:00:00 PM
- electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology • GlobeNewswire Inc. • 10/11/2023 12:00:00 PM
- Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress • GlobeNewswire Inc. • 10/10/2023 12:00:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM